PRLD compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name

PRLDPrelude Therapeutics Inc

Mkt capRevenueRevenue

LLYELI Lilly & Co

Mkt capRevenueRevenue

Compare

PRLDPrelude Therapeutics Inc

LLYELI Lilly & Co

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only PRLD 3

INCYIncytecustomer

ABCLAbCellera Biologicscustomer

—Pathos AIunlistedcustomer

Shared 0

No shared counterparties.

Only LLY 29

MCKMcKessoncustomer

CAHCardinal Healthcustomer

VEEVVeeva Systemssupplier

UTHRUnited Therapeuticscustomer

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

25 more · LLY chain ›

PRLDPrelude Therapeutics Inc

3.61▲+1.55%· post 3.61

Mkt cap$287.3MRevenue$6MQ2 FY26Revenue—

LLYELI Lilly & Co

1,360.90▼−0.28%· post 1,358.90

ClosedNov 6 '26

Mkt cap$1.2TRevenue$24.4BQ3 FY26Revenue$65.2BFY25

Compare

ClosedNov 6 '26

PRLDPrelude Therapeutics Inc

LLYELI Lilly & Co

3.61▲+1.55%post 3.61

Price

1,360.90▼−0.28%post 1,358.90

$287.3M

Mkt cap

$1.2T

Q2 FY26$6M

Revenue

$24.4BQ3 FY26

—

Revenue

$65.2BFY25

PRLD3.61▲+1.55%vsLLY1,360.90▼−0.28%ClosedNov 6 '26